Pancragen: Handling, Storage, and Reconstitution Guide

This Pancragen handling and storage guide covers laboratory best practices for working with the tetrapeptide as a lyophilized research material. It addresses reconstitution for in vitro preparation, cold-chain storage, aliquoting, and documentation, all framed as laboratory procedure. Pancragen (Lys-Glu-Asp-Trp, KEDW; C26H36N6O9; molecular weight near 576.61 g/mol) is supplied strictly for research use.

Pancragen Handling and Storage Fundamentals

Pancragen ships as a solid, white lyophilized powder in a sealed glass vial. Store the lyophilized material at or below 25 degrees Celsius, sealed and protected from heat, light, and moisture. For extended storage, keep it lyophilized and refrigerated or frozen, which slows degradation of the peptide over the study period. A CAS number is not established for this sequence, so identity should be confirmed by the certificate of analysis rather than by a registry lookup.

Because the aromatic tryptophan residue in KEDW is sensitive to light and oxidation, protecting the vial from direct light is more than a formality. Maintaining consistent storage conditions and logging them is what keeps material integrity comparable across a study. Laboratories running parallel bioregulator work often align these practices with the Ovagen handling guide so the whole panel is stored under one documented standard.

Reconstitution for In Vitro Preparation

For in vitro work, Pancragen is reconstituted with bacteriostatic water added slowly down the vial wall, then swirled gently rather than shaken. Gentle handling limits foaming and mechanical stress on the peptide. As a small tetrapeptide, Pancragen generally dissolves readily, but working concentration should follow the assay design rather than a fixed formula. Prepare under clean conditions with calibrated pipettes and appropriate PPE.

This is reagent preparation for laboratory assays, not a route of administration, and it is not human-use or veterinary-use guidance. Concentration choices and solvent selection tie back to the model systems described in the Pancragen research applications, so preparation and study design should be planned together.

Aliquoting and Freeze-Thaw

Dividing reconstituted material into single-use aliquots limits repeated freeze-thaw cycles, which can degrade peptides and introduce variability. Label each aliquot with compound name, concentration, lot number, and date, and log storage location so the cold chain stays auditable from vial to bench.

• Reconstitute with bacteriostatic water for in vitro preparation only.
• Add solvent slowly down the vial wall and swirl gently rather than shaking.
• Aliquot into single-use volumes to avoid repeated freeze-thaw cycles.
• Label and log every aliquot with lot, concentration, and date.

Documentation and COA Verification

Each Pancragen batch ships with a third-party-verified certificate of analysis documenting purity by HPLC or reverse-phase chromatography, mass-spectrometry identity confirmation, and lot number, testing date, and method details. Because Pancragen has no established CAS number, this identity documentation is the primary way to confirm the KEDW sequence and molecular weight of a given batch.

Recording the lot number against results ties data to a specific batch and supports the reproducibility of the readouts discussed in the Pancragen mechanism of action. Sample certificates of analysis can be requested before purchase, and material with full documentation is available on the Pancragen product page. Teams handling related bioregulators can compare the Livagen handling guide and the Crystagen handling guide to keep documentation consistent across the class.

Safety and Compliance

Handle Pancragen as a research chemical: qualified personnel only, work in accordance with institutional SOPs and chemical hygiene plans, use engineering controls where required, and dispose of material per institutional and applicable regulations. Wear appropriate PPE, including lab coat, gloves, and eye protection, and record handling activities as part of quality assurance.

Consistent storage, careful reconstitution, and complete records throughout the study period support quality assurance and audit readiness. These practices exist to preserve material integrity and traceability, which in turn underpin reliable, reproducible research results.

For research use only. Pancragen is an investigational research peptide and is not approved for human or veterinary use. All handling guidance refers to laboratory procedure only.